Global Antidiabetics Industry Thriving at 10.9% YoY Growth, Enroot to US$ 223 Billion by 2032 | Unveils FMI’s Comprehensive Analysis
The Global Antidiabetics Industry is experiencing a remarkable surge, showcasing a substantial increase in valuation from US$ 80.4 billion in 2021 to an estimated US$ [read full press release…]